Edward Wolin was named director of the Mount Sinai Center for Carcinoid and Neuroendocrine Tumors.
Walther Supportive Oncology Program at Indiana University School of Medicine has named James Cleary as director, where he will join the faculty in July to lead the program and will hold the Walther Senior Chair in Supportive Oncology. He will also be a professor of medicine.
A collaboration between Georgetown University and the Frederick National Laboratory for Cancer Research aims to expand research and training missions in the biomedical sciences for both institutions.
Bristol-Myers Squibb Company said the Yale Cancer Center has joined the International Immuno-Oncology Network, a global peer-to-peer collaboration between Bristol-Myers Squibb and academia that aims to advance translational Immuno-Oncology science.
Henry Fung and the Fox Chase-Temple University Hospital Bone Marrow Transplant Program willl receive the Andy Talley Bone Marrow Foundation's first “Game Changer Award” during the 7th Annual Bash March 3.
MD Anderson Cancer Center and RaySearch Laboratories formed a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors and improving upon, and making more available, an existing radiation therapy called adaptive radiation therapy, currently only used at highly specialized care centers.
Frederick Schnell was named medical director of the Community Oncology Alliance.
Northwell Health has appointed Richard Barakat to lead its cancer services and research.
Denis Guttridge will join the Medical University of South Carolina as director of the Charles P. Darby Children's Research Institute and associate director of translational sciences for the Hollings Cancer Center effective May 1.
The 2018 Szent-Györgyi Prize for Progress in Cancer Research will be awarded Douglas Lowy and John Schiller, of the NCI Center for Cancer Research for their contributions toward the development of vaccines for the human papillomavirus.
